Orthocell Ltd (OCC)

Sydney
0.395
-0.010(-2.47%)
  • Volume:
    339,681
  • Bid/Ask:
    0.395/0.415
  • Day's Range:
    0.395 - 0.420

OCC Overview

Prev. Close
0.405
Day's Range
0.395-0.42
Revenue
1.42M
Open
0.42
52 wk Range
0.3-0.59
EPS
-0.05
Volume
339,681
Market Cap
78.85M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
284,679
P/E Ratio
-
Beta
1.36
1-Year Change
-21.5%
Shares Outstanding
197,127,913
Next Earnings Date
-
What is your sentiment on Orthocell Ltd?
or
Market is currently closed. Voting is open during market hours.

Orthocell Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Orthocell Ltd Company Profile

Orthocell Ltd Company Profile

Employees
0
Market
Australia

Orthocell Limited is an Australia-based regenerative medicine company. The Company is engaged in the development and commercialization of collagen medical devices and cell therapies for the repair and regeneration of human tendons, bone, nerve and cartilage defects. Its portfolio of products includes CelGro, Striate+, Remplir and SmrtGraft. The CelGro product is a collagen medical device, which facilitates tissue repair and healing in a variety of dental and orthopaedic reconstructive applications. Its Striate+ product is approved for dental guided bone regeneration (GBR) applications and is cleared for use in the United States Food and Drug Administration (FDA), Australia (ARTG) and Europe (CE Mark). Its Remplir product is for peripheral nerve repair, which has received approval in Australia (ARTG). Its SmrtGraft product is for tendon repair that is available in Australia under Special Access Scheme or participation in a clinical trial.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell